The ADNI2 phase of the study commenced in 2011 and is modeled after the original ADNI study.
In the 2×2 phase of the study, children with malaria were initially openly randomised to receive a therapeutic dose regime of chloroquine plus sulfadoxine/pyrimethamine (CQ-SP) or co-artemether (ACT) (day 0).
The frequency of bacterial, viral, and parasitic pathogens identified during the 2 phases of the study are shown in Table 2.
Relationships between clinical parameters and changes of OHIP-49-H scores were investigated by stepwise multivariate logistic regression analysis comparing the T0- and T1-phases of the study, after dichotomizing the outcomes according to the observed median values.
Clinical assessment visits: Randomised participants attend these visits as part of the interventional (weeks 12, 24, 36 and 48) and the observational (weeks 60, 72, 84 and 96) phases of the study.
Across the 3 phases of the study (conditioning, extinction, and extinction recall), the one-way ANCOVAs revealed a significant main effect of Group in different sub-regions of the insular cortex (IC) (Fig. 1).
We could not confirm any hemodynamic advantage of HDF, as we did not observe any difference in the number of hypotensive episodes or changes in blood pressure values during the 3 phases of the study.
Comprehensive measurements of functional and structural aspects of social support were available in phase 2 (1989–1990), phase 5 (1997–1999), and phase 7 (2002–2004) of the study.
As such, our repetition scheme, intensity, and rest period lengths varied from workout to workout, from week to week, and from phase 1 through phase 3 of the study (Tables 1, 2, 3).
In the first 14-month phase of the study (2002 2003, two schools), 42 from the intervention and 46 from the control school participated.
